Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP711699.RAa5OjGWW2gFCAlmtSXeepmeCXpWAA8JxgG0iRqmff0dU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP711699.RAa5OjGWW2gFCAlmtSXeepmeCXpWAA8JxgG0iRqmff0dU130_assertion type Assertion NP711699.RAa5OjGWW2gFCAlmtSXeepmeCXpWAA8JxgG0iRqmff0dU130_head.
- NP711699.RAa5OjGWW2gFCAlmtSXeepmeCXpWAA8JxgG0iRqmff0dU130_assertion description "[Ab-based CD73 cancer therapy should include a combination of Abs that target the catalytic activity of CD73, as well as those with the characteristics described in this article.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP711699.RAa5OjGWW2gFCAlmtSXeepmeCXpWAA8JxgG0iRqmff0dU130_provenance.
- NP711699.RAa5OjGWW2gFCAlmtSXeepmeCXpWAA8JxgG0iRqmff0dU130_assertion evidence source_evidence_literature NP711699.RAa5OjGWW2gFCAlmtSXeepmeCXpWAA8JxgG0iRqmff0dU130_provenance.
- NP711699.RAa5OjGWW2gFCAlmtSXeepmeCXpWAA8JxgG0iRqmff0dU130_assertion SIO_000772 24043904 NP711699.RAa5OjGWW2gFCAlmtSXeepmeCXpWAA8JxgG0iRqmff0dU130_provenance.
- NP711699.RAa5OjGWW2gFCAlmtSXeepmeCXpWAA8JxgG0iRqmff0dU130_assertion wasDerivedFrom befree-20140225 NP711699.RAa5OjGWW2gFCAlmtSXeepmeCXpWAA8JxgG0iRqmff0dU130_provenance.
- NP711699.RAa5OjGWW2gFCAlmtSXeepmeCXpWAA8JxgG0iRqmff0dU130_assertion wasGeneratedBy ECO_0000203 NP711699.RAa5OjGWW2gFCAlmtSXeepmeCXpWAA8JxgG0iRqmff0dU130_provenance.